用P. pastoris的pAOX1表达系统表达木糖异构酶

目的:应用P. pastoris的pAOX1表达系统分泌表达重组木糖异构酶.方法:用PCR法从大肠杆菌基因组中扩增木糖异构酶基因(xi).用EcoRⅠ和NotⅠ双酶切将其基因克隆进P. pastoris表达载体.通过电转法将其木糖异构酶基因重组于P. pastoris基因组,筛选G418抗性700μg/ml的重组子作为工程菌GS115(pPIC9K-xi).在摇瓶中发酵用甲醇诱导表达重组木糖异构酶.用SDS-PAGE分析重组蛋白的表达情况,用糖酵解法对表达产物进行活性分析.结果:木糖异构酶基因在pAOX1的调控下,在P. pastoris中经甲醇诱导能分泌表达,摇瓶发酵2d表达量为35mg/L,表达产物具有代谢木糖的作用.结论:成功地克隆了大肠杆菌的木糖异构酶基因,并实现用pAOX1系统在P. pastoris中表达中木糖异构酶,为用P. pastoris规模化生产重组木糖异构酶奠定了基础.     

玉米淀粉分支酶基因的克隆与RNAi表达载体的构建

利用网络数据库http://jura.wi.mit.edu/bioc/siRNAext/,确定玉米淀粉分支酶SBEⅡb的部分基因序列作为RNAi的目标序列,通过RT-PCR方法从玉米自交系‘综31’中分别成功克隆出了玉米淀粉分支酶sbeⅡb基因的部分序列及其启动子序列,从大肠杆菌中成功克隆了木糖异构酶基因xylA作为筛选标记,构建了含有35S驱动的木糖异构酶基因和sbeⅡb启动子驱动的含有sbeⅡb目标序列的反向重复序列的表达载体pBAC413,并对玉米自交系实施转化。经PCR检测转基因玉米再生植株,初步判定目的序列已经成功整合到玉米再生植株的基因组中。     

以木糖异构酶基因xylA为选择标记的Gateway系统植物表达载体的构建

目的:构建以木糖异构酶基因xylA为筛选标记的无抗生素标记Gateway系统植物表达载体。方法:克隆大肠杆菌木糖异构酶基因xylA并用其替换植物表达载体pCAMBIA1301中的hpt基因,利用载体中的多克隆位点将Gateway Binary Vector(pH7WG2D)中酶切位点XbaⅠ和HindⅢ之间包括P35S、T35S、attR1、attR2和CmR-ccdB的片段重组入表达载体pCAMBIA1301中,构建表达载体pCAMBIA1301-xylA-GW,利用含有津田芜菁HY5基因片段的BP反应产物与载体进行LR反应,获得含有目的基因的植物表达载体pCAMBIA1301-xylA-HY5,并导入根癌农杆菌LBA4404中。结果:抗生素筛选及酶切和PCR鉴定表明成功构建了以xylA为筛选标记的无抗生素标记植物表达载体pCAMBIA1301-xylA-HY5。结论:利用木糖异构酶基因xylA结合Gateway克隆技术构建无抗生素标记植物表达载体,可简化、方便植物转基因表达载体构建。     

木糖异构酶基因xylA表达载体构建

以大肠埃希菌MG1655的基因组为模板,通过PCR扩增获得木糖异构酶基因xylA。利用敲除编码对基因转录起负调控作用的lacIq基因的大肠埃希菌/谷氨酸棒杆菌穿梭质粒pEC-XK99E,酶连后转化大肠埃希菌BL21和谷氨酸棒杆菌ATCC 13032。成功构建出了具有大肠埃希菌BL21表达活性的木糖异构酶表达载体pEC(lacI-)-xylA。     

异源表达木糖异构酶基因对克雷伯氏菌合成1,3-丙二醇的影响

【目的】提高克雷伯氏菌胞内还原力以强化1,3-丙二醇合成。【方法】将来源于大肠杆菌的木糖异构酶基因在克雷伯氏菌中异源表达,构建重组菌。研究重组菌添加不同浓度木糖为辅底物与甘油共发酵过程中代谢产物和NADH的变化规律。【结果】与对照菌相比,重组菌细胞内还原力NADH提高了0.1?0.3倍,1,3-丙二醇产量达到23.31 g/L,提高20%,1,3-丙二醇转化率从0.60 mol/mol提高到0.73 mol/mol。【结论】木糖异构酶基因的表达强化了木糖代谢途径,经磷酸戊糖途径积累大量还原力,促进了1,3-丙二醇的生成。     

在酿酒酵母中共表达XYLA和XKS1基因后利用木糖的初步研究

为了使酿酒酵母较好地利用木糖产生乙醇,将来自Thermus thermophilus的木糖异构酶基因XYLA和酿酒酵母自身的木酮糖激酶基因XKS1,构建到酵母表达载体pESC-LEU中,导入酿酒酵母YPH499中,同时成功表达了两种酶基因。该菌以木糖为唯一碳源进行限氧发酵,木糖的利用率为9.64%,为宿主菌的4.17倍,产生2.22 mmol.L-1的乙醇。同时初步探讨了两种酶基因的表达量对酿酒酵母发酵木糖生成乙醇的影响。木糖异构酶对木糖的利用起关键性的作用,木酮糖激酶的过量表达不利于乙醇生成。     

代谢木糖重组谷氨酸棒杆菌的构建

为了使谷氨酸棒杆菌较好地利用木糖生产有机酸,将来自Escherichia coli K-12的木糖异构酶基因xylA构建到表达载体pXMJ19中,导入Corynebacterium glutamicum ATCC13032Δldh中,成功表达了该酶基因。结果表明:重组菌株在以木糖为唯一C源进行发酵时,木糖的消耗速率为0.54 g/(L·h),木糖异构酶比酶活约为0.54 U/mL;在以木糖和葡萄糖的混合糖为C源进行发酵时,菌株优先利用葡萄糖,在葡萄糖完全消耗后,菌株开始有效利用木糖;以木糖为唯一C源进行两阶段发酵时,琥珀酸的收率可达(0.62±0.003)g/g。     

以耐草甘膦2mG2-epsps基因为选择标记的玉米转化体系的建立

转化细胞的筛选和再生是植物遗传转化体系中重要的组成部分,筛选剂的选择和筛选压力的高低直接影响着外源基因的转化率。以草甘膦异丙胺盐为筛选剂,通过比较在不同的草甘膦浓度及筛选时间的条件下,玉米愈伤组织生长和分化情况,发现经1mM的草甘膦异丙胺盐筛选15d后玉米愈伤组织分化受到明显抑制,故以此作为玉米遗传转化实验中的筛选压力。通过基因枪轰击,将构建好的pMAGUHM载体（其上携带有抗草甘膦基因2mG2-epsps基因）转化到玉米愈伤组织,利用草甘膦筛选得到耐草甘膦植株80株,其中PCR检测阳性植株为36株,转化率为45％。     

链霉菌M1033 D－木糖异构酶的分子克隆

链霉菌M1033染色体DNA经BamH Ⅰ酶解后电泳,Southern转移。根据自测的链霉菌M1033 D－木糖异构酶氨基酸序列设计合成寡聚核苷酸探针x－2、x－3,以x－2、x－3及Am－pullariella sp3876 D-木糖异构酶基因(1．17kb)为探针进行杂交,确定与上述探针杂交最强处在15kb左右。从胶上分离出g-20kb大小的片段,克隆到EMBL 3载体中,经杂交筛选后,得到0．6％的阳性噬斑,其插人大小为13kh。将插入DNA的saIⅠ酶解片段(2．5kb)进一步亚克隆于pucl8,得到重组质粒puB l,经酶解图谱、部分序列分析和互补实验确定puBl含有完整的M1033 D-木糖异构酶基因     

E.coli木糖异构酶基因的克隆及表达条件的优化

采用PCR技术以大肠杆菌JM109基因组DNA为模板扩增得到木糖异构酶基因xylA,连接到载体pET-22b( ),得到重组质粒pET-22b( )-xylA。将此重组质粒转化到大肠杆菌菌株BL21(DE3)中,重组菌株经IPTG诱导后,通过半胱氨酸-咔唑法测得木糖异构酶活力。每mL发酵液中重组菌株显示出酶活力约为0.84 U。SDS-PAGE电泳结果显示出明显的5×104(相对分子质量)特异性蛋白质条带。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).